शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
NHNSENarayana Hrudayalaya Ltd.· Healthcare ServicesHighNeutral
Announced Fri, 14 Nov, 2025 · 19:56 IST

Narayana Hrudayalaya Ltd. has submitted to the Exchange, the financial results for the period ended September 30, 2025.

NH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+15.0%Reaction day
₹1757.00
prior close
₹1835.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.7%+14.3% vs market
Hospital peers, median of 20sector-0.0%+15.0% vs sector

On the reaction day the stock moved 14.3 pts more than Nifty Smallcap 250 and 15.0 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.6
10m
+2.1
15m
+2.9
30m
+3.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+15.0+0.7+14.3-0.0+15.0
Next day
+10.8-0.3+11.1-0.8+11.6
2d
+13.5-0.8+14.3-0.3+13.8
3d
+14.3-0.9+15.1+0.0+14.3
4d
+16.1-2.1+18.2-0.5+16.6
5d
+12.6-2.7+15.3-1.1+13.6
1w
+12.1-1.5+13.6-1.6+13.7
15d
+9.4-5.6+15.0-3.2+12.6
1m
+6.8-5.1+11.9-4.4+11.2
2m
+5.9-6.2+12.1-8.2+14.2
3m
+3.9-5.7+9.6-9.6+13.5
UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 20Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Narayana Hrudayalaya Ltd., a hospital chain operator listed on NSE, has submitted its unaudited/reviewed financial results for the quarter and half-year ended September 30, 2025 to the exchange. This is a routine regulatory filing required under SEBI's listing obligations for listed companies. The actual numbers including revenue, profit, and segment performance would be detailed in the full results document. Investors should refer to the company's detailed financial statement and press release for specific performance metrics.

Likely market impact

This is a standard periodic compliance filing with no direct stock price impact. Shareholders should review the detailed results to assess the hospital chain's revenue growth, margin trends, and expansion progress for the quarter.